COVID-19 RESEARCH UPDATES

We’re here to support researchers. Visit our COVID-19 page for links to emerging research, updates about our policies, and more resources related to the pandemic. View the page

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

Exciting new immunology research

PLOS Biology is home to high quality, original research with a broad scope across the biological sciences. We empower authors to share and get credit for their work and offer publishing options that boost the visibility of your science.

Combating antiscience: Are we preparing for the 2020s?

Peter J. Hotez

PERSPECTIVE


NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity

Marjan Gharagozloo, Shaimaa Mahmoud, Camille Simard, Kenzo Yamamoto, Diwakar Bobbala, et al

RESEARCH ARTICLE


Detecting T cell receptors involved in immune responses from single repertoire snapshots

Mikhail V. Pogorelyy, Anastasia A. Minervina, Mikhail Shugay, Dmitriy M. Chudakov, Yuri B. Lebedev,  et al
RESEARCH ARTICLE


Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody

Sunita Gulati, Frank J. Beurskens, Bart-Jan de Kreuk, Marcel Roza, Bo Zheng, et al

RESEARCH ARTICLE


Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats

Dan Lu, Kefang Liu, Di Zhang, Can Yue, Qiong Lu, et al
RESEARCH ARTICLE

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
Lieselotte Vande Walle, Irma B. Stowe, Pavel Šácha, Bettina L. Lee, Dieter Demon, et al
RESEARCH ARTICLE


LOOKING AHEAD

The future of PLOS Biology

Nonia Pariente, on behalf of the PLOS Biology Staff Editors

Editorial

Back to top